(Q54305674)

27 May 2018

title

SMARCB1/INI1 inactivation in renal medullary carcinoma. (English)

1 reference

27 May 2018

Olivier Delattre

12

0 references

author name string

Julien Calderaro

1

1 reference

27 May 2018

Julien Moroch

2

1 reference

27 May 2018

Gaelle Pierron

3

1 reference

27 May 2018

Florence Pedeutour

4

1 reference

27 May 2018

Camille Grison

5

1 reference

27 May 2018

Pascale Maillé

6

1 reference

27 May 2018

Pascale Soyeux

7

1 reference

27 May 2018

Alexandre de la Taille

8

1 reference

27 May 2018

Jérome Couturier

9

1 reference

27 May 2018

Annick Vieillefond

10

1 reference

27 May 2018

Marie Christine Rousselet

11

1 reference

27 May 2018

Yves Allory

13

1 reference

27 May 2018

publication date

11 June 2012

1 reference

27 May 2018

published in

Histopathology

1 reference

27 May 2018

volume

61

1 reference

27 May 2018

issue

3

1 reference

27 May 2018

page(s)

428-435

1 reference

27 May 2018

Renal medullary carcinoma: the Bronx experience

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2012.04228.X

Uncommon and recently described renal carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2012.04228.X

ALK rearrangement in sickle cell trait-associated renal medullary carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2012.04228.X

Renal medullary carcinoma and ABL gene amplification

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2012.04228.X

The role of SMARCB1/INI1 in development of rhabdoid tumor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2012.04228.X

Haploinsufficiency of Snf5 (integrase interactor 1) predisposes to malignant rhabdoid tumors in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2012.04228.X

Loss of the hSNF5 gene concomitantly inactivates p21CIP/WAF1 and p16INK4a activity associated with replicative senescence in A204 rhabdoid tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2012.04228.X

Re-expression of hSNF5/INI1/BAF47 in pediatric tumor cells leads to G1 arrest associated with induction of p16ink4a and activation of RB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2012.04228.X

hSNF5/INI1-deficient tumours and rhabdoid tumours are convergent but not fully overlapping entities

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2012.04228.X

Epithelioid sarcoma: a clinicopathologic and immunohistochemical analysis of 106 cases from the French sarcoma group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2012.04228.X

SMARCB1/INI1 tumor suppressor gene is frequently inactivated in epithelioid sarcomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2012.04228.X

Truncating mutations of hSNF5/INI1 in aggressive paediatric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2012.04228.X

Constitutional mutations of the hSNF5/INI1 gene predispose to a variety of cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2012.04228.X

The SWI/SNF complex and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2012.04228.X

Infrequent SMARCB1/INI1 gene alteration in epithelioid sarcoma: a useful tool in distinguishing epithelioid sarcoma from malignant rhabdoid tumor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2012.04228.X

Renal medullary carcinoma: report of seven cases from Brazil

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2012.04228.X

Renal medullary carcinoma: molecular, pathological and clinical evidence for treatment with topoisomerase-inhibiting therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2012.04228.X

Gene expression profiling of renal medullary carcinoma: potential clinical relevance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2012.04228.X

Loss of the epigenetic tumor suppressor SNF5 leads to cancer without genomic instability.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2012.04228.X

The theoretical basis of transcriptional therapy of cancer: can it be put into practice?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2012.04228.X

Epigenetic and chromatin modifiers as targeted therapy of hematologic malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2012.04228.X

Inhibitors of histone deacetylases as potential therapeutic tools for high-risk embryonal tumors of the nervous system of childhood

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2012.04228.X

Frequent hSNF5/INI1 Germline Mutations in Patients with Rhabdoid Tumor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2012.04228.X

10.1111/J.1365-2559.2012.04228.X

21 January 2018

Identifiers

DOI

1 reference

27 May 2018

1 reference

27 May 2018